Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,755
Closed -$207K 348
2026
Q1
$207K Buy
1,755
+53
+3% +$6.55K 0.02% 266
2025
Q4
$214K Buy
+1,702
New +$222K 0.02% 266
2025
Q2
Sell
-23,966
Closed -$3.95M 427
2025
Q1
$3.95M Buy
23,966
+351
+1% +$58.4K 0.41% 49
2024
Q4
$3.85M Buy
23,615
+6,661
+39% +$1.19M 0.37% 45
2024
Q3
$3.31M Buy
16,954
+2,044
+14% +$377K 0.36% 53
2024
Q2
$2.58M Buy
14,910
+3,392
+29% +$564K 0.31% 63
2024
Q1
$1.95M Buy
11,518
+8,252
+253% +$1.55M 0.25% 74
2023
Q4
$645K Buy
3,266
+69
+2% +$12.2K 0.08% 174
2023
Q3
$556K Buy
3,197
+81
+3% +$14.7K 0.09% 177
2023
Q2
$537K Buy
+3,116
New +$539K 0.08% 167
2017
Q4
Sell
-61
Closed -$3K 439
2017
Q3
$3K Buy
+61
New +$3.82K ﹤0.01% 317

Other funds holding ZTS

Legacy Advisors's ZTS Position: Q2 2026 in Review

Legacy Advisors sold out of Zoetis (ZTS) in Q2 2026, closing a stake of 1,755 shares — an estimated $207K sold.

Legacy Advisors first reported a position in ZTS in Q3 2017 and held it in 11 quarters. The position peaked at $3.95M in Q1 2025. 385 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Legacy Advisors reported no remaining Zoetis position as of Q2 2026 after selling out during the quarter.
  • Legacy Advisors sold 1,755 Zoetis shares in Q2 2026, an estimated $207K.
  • Legacy Advisors first reported a position in Zoetis in Q3 2017 and held it in 11 quarters.
  • Legacy Advisors's Zoetis position peaked at $3.95M in Q1 2025.
  • 385 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Legacy Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.